Journal Information
Most cited
105
STAT3: A key regulator in liver fibrosisJie Zhao, Yong-Fen Qi, Yan-Rong Yu
Ann Hepatol. 2021;21C:224
105
Open access
84
Liver disease and outcomes among COVID-19 hospitalized patients – A systematic review and meta-analysisAshish Sharma, Pragya Jaiswal, Yasameen Kerakhan, Lakshmi Saravanan, Zeba Murtaza, Azka Zergham, Nagaraj-Sanchitha Honganur, Aelia Akbar, ... Preeti Malik
Ann Hepatol. 2021;21C:273
84
Open access
Open Article
79
Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review articleMohamad Mouchli, Shravani Reddy, Miranda Gerrard, Lisa Boardman, Marrieth Rubio
Ann Hepatol. 2021;22C:249
79
Open access
58
The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studiesUmar Hayat, Ali A. Siddiqui, Hayrettin Okut, Saba Afroz, Syed Tasleem, Ahmed Haris
Ann Hepatol. 2021;20C:254
58
Open access
44
Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)Ivan Lopez-Mendez, Jorge Aquino-Matus, Sofia Murua-Beltrán Gall, Jose D. Prieto-Nava, Eva Juarez-Hernandez, Misael Uribe, Graciela Castro-Narro
Ann Hepatol. 2021;20C:271
44
Open access
Open Article
39
Silymarin is an ally against insulin resistance: A reviewKarla MacDonald-Ramos, Layla Michán, Alejandra Martínez-Ibarra, Marco Cerbón
Ann Hepatol. 2021;23C:255
39
Open access
38
Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 casesFaxiang Chen, Wei Chen, Jianpu Chen, Dan Xu, Wei Xie, Xiang Wang, Yuanliang Xie
Ann Hepatol. 2021;21C:267
38
Open access
Open Article
33
Standardization of conventional chemoembolization for hepatocellular carcinomaMatteo Renzulli, Giuliano Peta, Francesco Vasuri, Giovanni Marasco, Daniele Caretti, Laura Bartalena, Daniele Spinelli, Emanuela Giampalma, ... Rita Golfieri
Ann Hepatol. 2021;22C:278
33
Open access
31
The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formationQifan Lu, Zhaoyan Jiang, Qihan Wang, Hai Hu, Gang Zhao
Ann Hepatol. 2021;23C:100289
31
Open access
29
LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathwayTao Wan, Jun Zheng, Rucheng Yao, Shuang Yang, Weihong Zheng, Pei Zhou
Ann Hepatol. 2021;20C:258
29
Open access